AB0465 Association between safety, efficacy and hydroxychloroquine dosage in the treatment of cutaneous lupus erythematosus and systemic lupus erythematosus
AB0465 Association between safety, efficacy and hydroxychloroquine dosage in the treatment of cutaneous lupus erythematosus and systemic lupus erythematosus